BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 34454591)

  • 1. 2-Hydroxybenzylamine (2-HOBA) to prevent early recurrence of atrial fibrillation after catheter ablation: protocol for a randomized controlled trial including detection of AF using a wearable device.
    O'Neill MJ; Yoneda ZT; Crawford DM; Ye F; Ao M; Pitchford LM; Rathmacher JA; Murray KT; Akers WS; Roden DM; Michaud GF; Shoemaker MB
    Trials; 2021 Aug; 22(1):576. PubMed ID: 34454591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly Reactive Isolevuglandins Promote Atrial Fibrillation Caused by Hypertension.
    Prinsen JK; Kannankeril PJ; Sidorova TN; Yermalitskaya LV; Boutaud O; Zagol-Ikapitte I; Barnett JV; Murphy MB; Subati T; Stark JM; Christopher IL; Jafarian-Kerman SR; Saleh MA; Norlander AE; Loperena R; Atkinson JB; Fogo AB; Luther JM; Amarnath V; Davies SS; Kirabo A; Madhur MS; Harrison DG; Murray KT
    JACC Basic Transl Sci; 2020 Jun; 5(6):602-615. PubMed ID: 32613146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolevuglandins Promote Mitochondrial Dysfunction and Electrophysiologic Abnormalities in Atrial Cardiomyocytes.
    Subati T; Yang Z; Murphy MB; Stark JM; Trykall DZ; Davies SS; Barnett JV; Murray KT
    Cells; 2024 Mar; 13(6):. PubMed ID: 38534327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Atrial Fibrillation Episode Duration With Arrhythmia Recurrence Following Ablation: A Secondary Analysis of a Randomized Clinical Trial.
    Andrade JG; Deyell MW; Verma A; Macle L; Champagne J; Leong-Sit P; Novak P; Badra-Verdu M; Sapp J; Khairy P; Nattel S
    JAMA Netw Open; 2020 Jul; 3(7):e208748. PubMed ID: 32614422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Renal Denervation and Catheter Ablation vs Catheter Ablation Alone on Atrial Fibrillation Recurrence Among Patients With Paroxysmal Atrial Fibrillation and Hypertension: The ERADICATE-AF Randomized Clinical Trial.
    Steinberg JS; Shabanov V; Ponomarev D; Losik D; Ivanickiy E; Kropotkin E; Polyakov K; Ptaszynski P; Keweloh B; Yao CJ; Pokushalov EA; Romanov AB
    JAMA; 2020 Jan; 323(3):248-255. PubMed ID: 31961420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insertable cardiac monitor-guided early intervention to reduce atrial fibrillation burden following catheter ablation: Study design and clinical protocol (ICM-REDUCE-AF trial).
    Tankut SS; Huang DT; Zareba W; Aktas MK; Rosero SZ; Steinberg J; Henchen J; Kutyifa V; Strawderman RL; Goldenberg I
    Ann Noninvasive Electrocardiol; 2023 Mar; 28(2):e13043. PubMed ID: 36718801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acupuncture for persistent atrial fibrillation after catheter ablation: study protocol for a pilot randomized controlled trial.
    Lin Y; Wang X; Li XB; Wu BQ; Zhang ZH; Guo WH; Wu CC; Chen X; Chen ML; Dai Z; Chen FY; Zhu R; Liang CX; Tian YP; Yang G; Yan CQ; Lu J; Wang HY; Li JL; Tu JF; Li HW; Yang DD; Yu FT; Wang Y; Yang JW; Shi GX; Yan SY; Wang LQ; Liu CZ
    Trials; 2021 Jan; 22(1):35. PubMed ID: 33413569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation Biomarker Response to Oral 2-Hydroxybenzylamine (2-HOBA) Acetate in Healthy Humans.
    Rathmacher JA; Fuller JC; Abumrad NN; Flynn CR
    Inflammation; 2023 Aug; 46(4):1343-1352. PubMed ID: 36935449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Common genetic variants and response to atrial fibrillation ablation.
    Shoemaker MB; Bollmann A; Lubitz SA; Ueberham L; Saini H; Montgomery J; Edwards T; Yoneda Z; Sinner MF; Arya A; Sommer P; Delaney J; Goyal SK; Saavedra P; Kanagasundram A; Whalen SP; Roden DM; Hindricks G; Ellis CR; Ellinor PT; Darbar D; Husser D
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):296-302. PubMed ID: 25684755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolevuglandin scavenger attenuates pressure overload-induced cardiac oxidative stress, cardiac hypertrophy, heart failure and lung remodeling.
    Shang L; Weng X; Wang D; Yue W; Mernaugh R; Amarnath V; Weir EK; Dudley SC; Xu Y; Hou M; Chen Y
    Free Radic Biol Med; 2019 Sep; 141():291-298. PubMed ID: 31254620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control]).
    Parkash R; Wells GA; Sapp JL; Healey JS; Tardif JC; Greiss I; Rivard L; Roux JF; Gula L; Nault I; Novak P; Birnie D; Ha A; Wilton SB; Mangat I; Gray C; Gardner M; Tang ASL
    Circulation; 2017 May; 135(19):1788-1798. PubMed ID: 28228428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and Design of FIRE AND ICE: A multicenter randomized trial comparing efficacy and safety of pulmonary vein isolation using a cryoballoon versus radiofrequency ablation with 3D-reconstruction.
    Fürnkranz A; Brugada J; Albenque JP; Tondo C; Bestehorn K; Wegscheider K; Ouyang F; Kuck KH
    J Cardiovasc Electrophysiol; 2014 Dec; 25(12):1314-20. PubMed ID: 25146732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrence of arrhythmia following short-term oral AMIOdarone after CATheter ablation for atrial fibrillation: a double-blind, randomized, placebo-controlled study (AMIO-CAT trial).
    Darkner S; Chen X; Hansen J; Pehrson S; Johannessen A; Nielsen JB; Svendsen JH
    Eur Heart J; 2014 Dec; 35(47):3356-64. PubMed ID: 25182250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cryoballoon pulmonary vein isolation as first line treatment for typical atrial flutter (CRAFT): study protocol for a randomised controlled trial.
    Ding WY; Williams E; Das M; Tovmassian L; Tayebjee M; Haywood G; Martin C; Rajappan K; Bates M; Temple IP; Reichlin T; Chen Z; Balasubramaniam R; Ronayne C; Clarkson N; Mahida S; Sticherling C; Gupta D
    J Interv Card Electrophysiol; 2021 Apr; 60(3):427-432. PubMed ID: 32385774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colchicine to Prevent Atrial Fibrillation Recurrence After Catheter Ablation: A Randomized, Placebo-Controlled Trial.
    Benz AP; Amit G; Connolly SJ; Singh J; Acosta-Vélez JG; Conen D; Deif B; Divakaramenon S; McIntyre WF; Mtwesi V; Roberts JD; Wong JA; Zhao R; Healey JS;
    Circ Arrhythm Electrophysiol; 2024 Jan; 17(1):e01238. PubMed ID: 38126206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryoballoon versus radiofrequency for pulmonary vein re-isolation after a failed initial ablation procedure in patients with paroxysmal atrial fibrillation.
    Pokushalov E; Romanov A; Artyomenko S; Baranova V; Losik D; Bairamova S; Karaskov A; Mittal S; Steinberg JS
    J Cardiovasc Electrophysiol; 2013 Mar; 24(3):274-9. PubMed ID: 23210695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryoballoon or Radiofrequency Ablation for Atrial Fibrillation Assessed by Continuous Monitoring: A Randomized Clinical Trial.
    Andrade JG; Champagne J; Dubuc M; Deyell MW; Verma A; Macle L; Leong-Sit P; Novak P; Badra-Verdu M; Sapp J; Mangat I; Khoo C; Steinberg C; Bennett MT; Tang ASL; Khairy P;
    Circulation; 2019 Nov; 140(22):1779-1788. PubMed ID: 31630538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy and safety of radiofrequency catheter ablation of atrial fibrillation in patients with cardiac implantable electronic devices and transvenous leads.
    Dinshaw L; Schäffer B; Akbulak Ö; Jularic M; Hartmann J; Klatt N; Dickow J; Gunawardene M; Münkler P; Hakmi S; Pecha S; Sultan A; Lüker J; Pinnschmidt H; Hoffmann B; Gosau N; Eickholt C; Willems S; Steven D; Meyer C
    J Cardiovasc Electrophysiol; 2019 May; 30(5):679-687. PubMed ID: 30821012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atorvastatin for prevention of atrial fibrillation recurrence following pulmonary vein isolation: a double-blind, placebo-controlled, randomized trial.
    Suleiman M; Koestler C; Lerman A; Lopez-Jimenez F; Herges R; Hodge D; Bradley D; Cha YM; Brady PA; Munger TM; Asirvatham SJ; Packer DL; Friedman PA
    Heart Rhythm; 2012 Feb; 9(2):172-8. PubMed ID: 21920481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remote-controlled magnetic pulmonary vein isolation using a new three-dimensional non-fluoroscopic navigation system: a single-centre prospective study.
    Da Costa A; Ben H'dech M; Romeyer-Bouchard C; Bisch L; Gate-Martinet A; Levallois M; Isaaz K
    Arch Cardiovasc Dis; 2013; 106(8-9):423-32. PubMed ID: 23906679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.